ScholarLens Back to search
1970•Archives of SurgeryRequires access

Failure of Clinical Dextran to Prevent Infusion Phlebitis

Adolf Singer

Open publisher page 1 citations

Abstract

Alternate intravenously administered infusions in 127 surgical patients had 500 ml of clinical dextran 75 added per day. The degree of phlebitis at the site of infusion was evaluated at the time of its discontinuation. The incidence of infusion phlebitis was found to be 30% in both treated and control groups, volume and duration of infusion being comparable. These results are discussed in relation to the value of dextran in the prevention and treatment of thrombophlebitis.

About this research paper

What this paper is about

Alternate intravenously administered infusions in 127 surgical patients had 500 ml of clinical dextran 75 added per day. The degree of phlebitis at the site of infusion was evaluated at the time of its discontinuation. The incidence of infusion phlebitis was found to be 30% in both treated and control groups, volume and duration of infusion being comparable. These results are discussed in relation to the value of dextran in the prevention and treatment of thrombophlebitis.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Alternate intravenously administered infusions in 127 surgical patients had 500 ml of clinical dextran 75 added per day. The degree of phlebitis at the site of infusion was evaluated at the time of its discontinuation. The incidence of infusion phlebitis was found to be 30% in both treated and control groups, volume and duration of infusion being comparable. These results are discussed in relation to the value of dextran in the prevention and treatment of thrombophlebitis.

Key concepts: Medicine, Discontinuation, Thrombophlebitis, Dextran, Surgery, Anesthesia, Incidence (geometry), Thrombosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Failure of Clinical Dextran to Prevent Infusion Phlebitis — Research Paper | ScholarLens